SPOC domain proteins in health and disease
LM Appel, J Benedum, M Engl, S Platzer… - Genes & …, 2023 - genesdev.cshlp.org
Since it was first described> 20 yr ago, the SPOC domain (Spen paralog and ortholog C-
terminal domain) has been identified in many proteins all across eukaryotic species. SPOC …
terminal domain) has been identified in many proteins all across eukaryotic species. SPOC …
Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts
L Zhang, Y Wang, L Wang, M Wang, S Li, J He… - Journal of Molecular …, 2024 - Springer
Although immune checkpoint inhibitors have led to durable clinical response in multiple
cancers, only a small proportion of patients respond to this treatment. Therefore, we aim to …
cancers, only a small proportion of patients respond to this treatment. Therefore, we aim to …
Clinical features and prognostic biomarkers of patients with the rare SMACRA4 gene mutation in non-small cell lung cancer
J LONG, Y Chen, X Luo, C Wang, Y Guo, J Xu, P Lin… - 2023 - researchsquare.com
Background: Non-small cell lung cancer carrying SMARCA4 mutations is characterized by a
high degree of malignancy and a poor prognosis. Due to the rarity of the population and the …
high degree of malignancy and a poor prognosis. Due to the rarity of the population and the …
[引用][C] SPOC domain proteins in health and disease
A Schleiffer, X Strobl, D Slade - 2023 - europepmc.org
Since it was first described> 20 yr ago, the SPOC domain (Spen paralog and ortholog C-
terminal domain) has been identified in many proteins all across eukaryotic species. SPOC …
terminal domain) has been identified in many proteins all across eukaryotic species. SPOC …